Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation
- Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation. Tun�can, �zlem G�zel; Aki, Sahika Zeynep; Aky�rek, Nalan; Sucak, G�lsan; Senol, Esin // Journal of Infection in Developing Countries;May2011, Vol. 5 Issue 5, p406
Cutaneous aspergillosis is very rare and occurs predominantly in immunocompromised patients including transplant recipients. We report a 26-year-old male with acute lymphoblastic leukemia who developed cutaneous aspergillosis after undergoing combined immunosuppressive treatment including...
- Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. Poon, L M; Bassett Jr, R; Rondon, G; Hamdi, A; Qazilbash, M; Hosing, C; Jones, R B; Shpall, E J; Popat, U R; Nieto, Y; Worth, L L; Cooper, L; De Lima, M; Champlin, R E; Kebriaei, P // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p666
For patients with ALL who relapse following allo-SCT, only a second SCT provides a realistic chance for long-term disease remission. We retrospectively analyzed the outcomes of 31 patients with relapsed ALL after a prior allo-SCT, who received a second SCT (SCT2) at our center. With a median...
- Allogeneic HSCT improved outcomes for children with relapsed ALL. // Hem/Onc Today;8/10/2013, Vol. 14 Issue 15, p20
The article discusses research in Germany on the benefit of allogeneic hematopoietic stem cell transplantation (HSCT) in improving the prognosis of patients with acute lymphoblastic leukemia (ALL), referencing a study by C. Eckert published in an issue of the "Journal of Clinical Oncology."
- Epidemic Investigation of the Jaundice Outbreak in Girdharnagar, Ahmedabad, Gujarat, India, 2008. Chauhan, Naresh T.; Prajapati, Prakash; Trivedi, Atul V.; Bhagyalaxmi, A. // Indian Journal of Community Medicine;Apr2010, Vol. 35 Issue 2, p294
Background: Since 1976, seven outbreaks of hepatitis E occurred in Ahmedabad. Clusters of jaundice cases were reported on June 19, 2008, by a civic center, Girdharnagar ward, Ahmedabad. Objectives: The objectives were as follows: (1) to identify the etiological agent, source of outbreak, and...
- Reduced-intensity conditioning improved non-relapse mortality in acute lymphoblastic leukemia. // Hem/Onc Today;10/10/2010, Vol. 11 Issue 19, p31
This article focuses on a study which examined the association between reduced-intensity conditioning allogeneic stem cell transplantation and non-relapse mortality in patients with acute lymphoblastic leukemia.
- Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. Mead, Adam // Current Medical Literature: Leukemia & Lymphoma;2014, Vol. 22 Issue 2, p63
The article discusses a study published in the "New England Journal of Medicine" on the efficacy of letermovir treatment in patients infected with cytomegalovirus (CMV) after undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). Topics discussed include acknowledgment of CMV...
- Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Shata, Mohamed T.; Daef, Enas A.; Zaki, Maysaa E.; Abdelwahab, Sayed F.; Marzuuk, Naglaa M.; Sobhy, Maha; Rafaat, Marwa; Abdelbaki, Liala; Nafeh, Mohamed A.; Hashem, Mohamed; El-Kamary, Samer S.; Shardell, Michelle D.; Mikhail, Nabiel N.; Strickland, George T.; Sherman, Kenneth E. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2012, Vol. 106 Issue 10, p613
Abstract: Although the seroprevalence of hepatitis E virus (HEV) is approximately 80% in adult Egyptians living in rural areas, symptomatic HEV-caused acute viral hepatitis (AVH) is sporadic and relatively uncommon. To investigate the dichotomy between HEV infection and clinical AVH,...
- Differential expression of miR-17âˆ¼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Scherr, M; Elder, A; Battmer, K; Barzan, D; Bomken, S; Ricke-Hoch, M; Schröder, A; Venturini, L; Blair, H J; Vormoor, J; Ottmann, O; Ganser, A; Pich, A; Hilfiker-Kleiner, D; Heidenreich, O; Eder, M // Leukemia (08876924);Mar2014, Vol. 28 Issue 3, p554
Despite advances in allogeneic stem cell transplantation, BCR-ABL-positive acute lymphoblastic leukaemia (ALL) remains a high-risk disease, necessitating the development of novel treatment strategies. As the known oncomir, miR-17âˆ¼92, is regulated by BCR-ABL fusion in chronic myeloid...
- Earning CME Credit. // Emerging Infectious Diseases;Feb2011, Vol. 17 Issue 2, p334
Quizzes about zoonosis in the bedroom and hepatitis E virus and neurologic disorders are presented.